Article info

Download PDFPDF
Quantitative pathologic features as predictors of long-term survival in patients with advanced ovarian cancer treated with cisplatin

Authors

  • P. J. Van Diest Institute for Pathology, Free University Hospital, Amsterdam, and Department of Internal Medicine, Section of Oncology, Academic Hospital Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • J. P.A. Baak Institute for Pathology, Free University Hospital, Amsterdam, and Department of Internal Medicine, Section of Oncology, Academic Hospital Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • J. Brugghe Institute for Pathology, Free University Hospital, Amsterdam, and Department of Internal Medicine, Section of Oncology, Academic Hospital Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • M. E.L. Van De Burg Institute for Pathology, Free University Hospital, Amsterdam, and Department of Internal Medicine, Section of Oncology, Academic Hospital Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • A. T. Van Oosterom Institute for Pathology, Free University Hospital, Amsterdam, and Department of Internal Medicine, Section of Oncology, Academic Hospital Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • J. P. Neijt Institute for Pathology, Free University Hospital, Amsterdam, and Department of Internal Medicine, Section of Oncology, Academic Hospital Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  1. Address for correspondence: Jan P. A. Baak, MD, PhD, FRCPath, Department of Pathology, Free University Hospital, PO Box 7057, NL-1007 MB Amsterdam, The Netherlands. Supported by grant 28–834 of the Praeventiefonds.

Citation

Van Diest PJ, Baak JP, Brugghe J, et al
Quantitative pathologic features as predictors of long-term survival in patients with advanced ovarian cancer treated with cisplatin

Publication history

  • First published April 1, 1994.
Online issue publication 
March 04, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.